The pair of Phase 2b clinical trials run by the HIV Vaccine Trials Network (HVTN) and the HIV Prevention Trials Network (HPTN) enrolled 4,625 participants at risk for HIV infection from communities in North and South America, Europe, and sub-Saharan Africa.
Bobedi ba diteko tsa moriana tsa Mokgahlelo wa 2b tse tsamaiswang ke HIV Vaccine Trials Network (HVTN) le HIV Prevention Trials Network (HPTN) di ngodisitse bankakarolo ba 4,625 ba kotsing ya tshwaetso ya HIV ho tswa ditjhabeng tsa Amerika Leboya le Borwa, Yuropo, le Afrika e ka Borwa ho Sahara.